We recently found that BRS-3 was endogenously expressed in B16 cells, the murine melanoma cell line, and generated BRS-3 knockout B16 cells (B16-KO) using CRISPR-Cas9 techniques [12]. This evidence concerns the gene BRS3 and melanoma.